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Abstract
Background: This study sought to describe the pattern of complementary/alternative medicine
(CAM) use among a group of patients with advanced breast cancer, to examine the main reasons
for their CAM use, to identify patient's information sources and their communication pattern with
their physicians.
Methods: Face-to-face structured interviews of patients with advanced-stage breast cancer at a
comprehensive oncology center.
Results: Seventy three percent of patients used CAM; relaxation/meditative techniques and herbal
medicine were the most common. The most commonly cited primary reason for CAM use was to
boost the immune system, the second, to treat cancer; however these reasons varied depending
on specific CAM therapy. Friends or family members and mass media were common primary
information source's about CAM.
Conclusions: A high proportion of advanced-stage breast cancer patients used CAM. Discussion
with doctors was high for ingested products. Mass media was a prominent source of patient
information. Credible sources of CAM information for patients and physicians are needed.
Background
The use of complementary and alternative therapies is in-
creasing, especially among patients with life-threatening
diseases such as AIDS and cancer, and traditionally de-
fined vulnerable populations, such as the elderly. [1–5]
Prior studies have estimated that the proportion of cancer
patients using CAM varied from 7 to 64%, [6], with higher
figures among breast cancer patients, ranging from 67% to
83%. [7,8] Postal or telephone surveys of large groups
have helped establish the rate of use of CAM therapies,
but such methods give limited information about the spe-
cific use pattern for any given patient, nor do they com-
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monly collect information on why specific CAM
modalities were chosen, or where the patient obtained the
information on particular CAM use. The objectives of this
study were to conduct structured face-to-face interviews
with advanced stage breast cancer patients in order to de-
scribe their patterns of use of CAM therapies and prod-
ucts, to understand their reasons for selecting specific
CAM therapy or product, and to identify their informa-
tion sources on the use of CAM therapies and products.
Consecutive patients with advanced-stage breast cancer
who were candidates for stem cell transplant at a compre-
hensive oncology center breast cancer program were re-
cruited. This study provides important insights into CAM
use among a group of patients with advanced disease,
who may be both more willing to "try anything" given
their poor prognosis and more likely for potential adverse
interactions between conventional therapy and CAM ther-
apies.
Methods
Participants
The study was conducted at a tertiary teaching hospital
with a comprehensive cancer center. The institutional re-
view board approved the study. Patients 18 to 62 years of
age were eligible for this study if they had histologically
proven resected breast cancer, Karnofsky performance sta-
tus greater than 80 (on 0–100 scale), life expectancy of at
least 6 months, and were appropriate candidates for the
breast cancer stem cell transplant program. Subjects who
had brain metastases, life threatening concurrent nonma-
lignant conditions, or any condition that compromised
their ability to give informed consent were excluded. Con-
secutive patients attending oncology clinics between
March 1997 and January 1998 were enrolled after in-
formed consent was obtained. All patients signed an in-
formed consent approved by the institutional Review
Board. The structured interviews were conducted prior to
their participation in a breast cancer stem cell transplant
program, which at the time the study was carried out was
a treatment being applied in the setting of high risk breast
cancer for which other therapies were not highly effective.
Patients were able to decline participation for any particu-
lar question at any point during the interview. The infor-
mation was kept confidential. No patient was paid to
participate in the study. Subjects were assured that refusal
to participate in the study would not affect their future
care in any way. Two trained research assistants conducted
the face-to-face interviews.
Structured interview
Before the questions were selected, a focus group (n = 6)
was held to explore how women with advanced stage
breast cancer perceived CAM therapies and their use of
CAM, as well as how they obtained information relating
to CAM services and products. Findings from this focus
group and measures cited from the literature were used to
construct a questionnaire. The questionnaire was devel-
oped and revised over a ten-week course. Two pilot tests
for use with breast cancer patients (n = 12) were conduct-
ed during this period. Two interviewers who were experi-
enced in interviewing cancer patients were trained in
conducting the face-to-face interview and administered all
the interviews in the study.
The questionnaire included a list of CAM practices, thera-
pies, and products: relaxation techniques (including tai
chi, yoga, or chi gong and other meditative techniques);
chiropractic manipulation; massage; imagery (or visuali-
zation); energy healing (including therapeutic touch); bi-
ofeedback; hypnosis; spiritual healing practices; herbal
medicine; special diets and supplements (e.g. macrobiotic
diets); megavitamin therapy, minerals, shark cartilage; ho-
meopathy; acupuncture; folk remedies; "underground" or
illicit drugs. If a patient respondent used any of the servic-
es or products during the six months prior to the inter-
view, then the interviewer would ask: the reasons for using
the particular CAM; when the use began and ended; what
the primary source of information was; and whether an
individual discussed the use of the particular CAM with
her regular physicians. Each individual was also asked
about her self-perceived knowledge about CAM ("Com-
pared with most people, how well informed would you
say you are about CAM?") Demographic information in-
cluding age, education, ethnicity, marital status, depend-
ence and support, and household income category were
also obtained.
Statistical analysis
Study participants were classified as either CAM users or
CAM nonusers according to whether or not they used at
least one CAM therapy in the past 6 months. Demograph-
ic variables included age, education, ethnicity, marital sta-
tus, and household income. Information on time of
diagnosis, stage of disease, and previous cancer treatments
received were abstracted from medical record. Differences
between CAM users and nonusers with respect to partici-
pant characteristics were assessed by χ 2 tests or Fisher's ex-
act tests for discrete variables, and Wilcoxon rank sum test
for continuous variables. Logistic regression analysis was
also conducted to examine the characteristics contributing
to CAM user or nonuser.[9] All P value tests were two-sid-
ed.
Since individual patients may use multiple CAM thera-
pies, we estimated the frequency distribution of the main
reason for overall CAM use by averaging individual esti-
mates of this frequency (i.e., we estimated the frequency
distribution on each individual over a potentially mixed
set of modalities and averaged these frequencies over in-
dividuals). In this way, all individuals, without regard toBMC Complementary and Alternative Medicine 2002, 2 http://www.biomedcentral.com/1472-6882/2/8
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the number of CAM modalities they used, were weighted
equally in the analysis. In a similar way, we estimated the
frequency distribution of the main source of information
on CAM with each individual given equal weight in the
analysis.
Results
Characteristics of participants
One hundred and fifteen consecutive patients were inter-
viewed and completed the face-to-face structured inter-
views without refusal. (They included 111 consecutive
patients who were about to undergo stem cell transplant
program and 4 patients who recently completed the pro-
gram.) Among them, 84 patients were users of CAM ther-
apies (73% of the study participants, C.I. 65% to 81%).
Overall, the mean age of all patients was 45.9 years (me-
dian 46, range, 27 to 63 years). About two-thirds of the
patients reported their ethnicity as white, the remainder of
the patients belonged to a wide range of ethnic groups.
Most had a college education, with an average of 15.2
years of completed education. Most had received surgery,
radiation, and all subjects had previously received chem-
otherapy for treatment of cancer. The majority of patients
were married. Comparing the characteristics between us-
ers and nonusers of CAM: (Table 1) Users of CAM had
more years of education when compared to nonusers (P <
.001, Wilcoxon ranksum test). Users and nonusers did not
differ significantly according to age, income, marital sta-
tus, and family support. After adjusting for covariates in
the multiple logistic regression analysis, which included
age, education, income, marital status, and family sup-
port, years of education still remained a predictor for use
of CAM (P < .001).
Perceived knowledge about CAM
CAM users perceived themselves to be better informed
about CAM than CAM nonusers. Patients were asked:
"Compared with most people, how well informed would
you say you are (about CAM)." They were ranked on a 1–
5 Lickert scale, with 1 = Much better informed than most
and 5 = Much less well informed than most. The CAM
nonusers group had an average of 3.2 (median 3; 3 =
About as well informed as most), the CAM users group
had an average of 2.3 (median 2; 2 = Somewhat better in-
formed than most). (P < .001, Wilcoxon ranksum test).
Complementary and alternative medicine use
Seventy three percent of the interviewed patients reported
using at least one category of CAM in the previous 6
months. Among the CAM users, people often used more
than one CAM modality or products in combination
(range 1–9 categories, mean 3.9, median 4). Figure 1
shows estimates of the percent use for various categories
of CAM therapies and products.
The vast majority of CAM users consumed CAM products.
The frequency and duration of use of CAM products var-
ied greatly, ranged from regular daily consumption to
sporadic use. The most commonly used CAM product was
"herbal medicine" category used by more than half of all
CAM users (and by 40% of all study participants, C.I. 25%
to 55%). Patients had a variety of sources to obtain their
herbal medicine: by mail order, in stores, from their chi-
ropractors, acupuncturists, and from friends and family
members. When asked whether their use of the CAM was
used in any integrative program or under professional su-
pervision, the majority of herbal medicine users (59%) re-
ported that they were not under the supervision of their
physicians nor herbalists.
A minority of patients visited CAM practitioners. Overall,
less than one third of the CAM users visited CAM practi-
tioners. Among users who visited at least one CAM practi-
tioner, the patterns of care they received from CAM
practitioners also varied greatly, ranging from a single iso-
lated visit to ongoing regular weekly visits.
Table 1: Characteristics of Participants: Users and Nonusers of CAM (N = 115)
Nonuser User P
Age, mean. years 44.9 46.3 0.44
Marital status, % married 74.2 70.2 0.81
Ethnicity, % white 64.0 70.0 0.46
Years of Education 13.5 15.7 <.001
Household Income Category (1–9) 5.8 6.1 0.25
Number of members in household (excluding self) 2.3 2.0 0.54
Discrete characteristics were compared by Chi square test or Fisher's exact tests. Continuous characteristics were compared by Wilcoxon rank 
sum test.BMC Complementary and Alternative Medicine 2002, 2 http://www.biomedcentral.com/1472-6882/2/8
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The primary reasons for CAM therapy use
Patients may have more than one reason to use a particu-
lar CAM therapy. When a patient reported a particular
CAM use, she was asked to provide a primary reason for
the particular CAM therapy use.
The primary reason for use varied according to CAM mo-
dality. Among patients who practiced tai chi, yoga, chi
gong or other relaxation and meditation techniques, the
two most frequently given primary reasons given were to
reduce stress and to boost the immune system. Among pa-
tients who took herbal medicine, the most commonly re-
ported primary reason was to cure cancer, followed by to
boost the immune system.
Forty percent of all the reasons given for using all CAM
products was to boost the immune system. The second
most common reason was to treat cancer (32%). The third
most common reason was to relieve symptoms and stress
associated with side effects of conventional treatments,
such as surgery, radiation, and chemotherapy (21%). Oth-
er primary reasons cited included stress reduction and de-
toxification.
Information source about CAM therapy use
Patients may have obtained information about a particu-
lar CAM use from multiple sources. When a patient re-
ported a particular CAM therapy use, she was asked to
provide the one primary information source about that
particular CAM therapy.
The primary information source on CAM therapy use var-
ied according to CAM modality. Among patients who
practiced tai chi, yoga, or chi gong or other relaxation and
meditation techniques, the two most common primary
information sources were mass media (including TV,
newspaper, magazine, video tapes, the Internet, and other
mass media) and friends or family members. Among pa-
tients who took herbal medicine, the two most common
primary information sources were also mass media and
friends or family members.
An overall estimate of the frequency distribution for the
most common primary information sources (without re-
gard to CAM modality) demonstrated that the two most
common primary information sources were friends or
family members (31%) and mass media (32%). Less com-
mon primary information sources were health profession-
als in conventional settings (16%, these included nurses,BMC Complementary and Alternative Medicine 2002, 2 http://www.biomedcentral.com/1472-6882/2/8
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nutritionists, physicians, pharmacists, social workers, and
other health care workers) and CAM practitioners (17%,
these included chiropractors, acupuncturists, herbalists,
message therapists, and other CAM workers).
Communication about CAM use with physicians
Figure 2 shows the percentage of patients who discussed
their CAM therapy by specific CAM modality. We found
that a high proportion of patients discussed their CAM use
with their physicians when they used herbal medicine or
other products they ingest (the exception was homeopa-
thy). Patients were less likely to discuss their CAM use
with their physicians when CAM use did not involve in-
gested products, such as chiropractic manipulation, im-
agery, spiritual healing, energy healing, hypnosis, and
acupuncture.
Discussion
Our study provides both some measure of reassurance
and raises concern about the use of CAM by patients with
advanced-stage breast cancer. First, we found that the vast
majority (73%) of our patients use CAM, a finding in line
with previous estimates [7,8]. Unlike previous studies
[10–12], we found that most patients using ingested CAM
products (herbs, special diets, supplements, and folk rem-
edies) discussed this use with their medical providers.
Making their physicians aware of the use of ingested CAM
products is a necessary first step toward preventing un-
wanted interactions with the multiple conventional med-
ications and care these patients also undertake [13–15].
By telling the doctors one might speculate that the pa-
tients wanted guidance from physicians to avoid poten-
tially harmful treatments and toxic interactions. This
illustrates the importance and need for physicians to
know about the toxicity and interactions and the evidence
for various ingested CAM products. Such information is
scarce thus well-designed clinical trails of these therapies
are needed.
The CAM modalities these patients discussed less fre-
quently with their physicians (yoga, meditation, imagery,
spiritual healing) seem unlikely to cause unwanted inter-
actions with concurrent care. Perhaps that is the reason
that patients disclose them less frequently. Another expla-
nation is that many physicians do not lend credence to
many of these CAM modalities, thus patients might be re-
luctant to discuss them. Credible information on efficacy
is also lacking this area. It is unclear whether the above se-
lective communication pattern is unique to a highly edu-
cated patient group with advanced cancer, or common to
other patient populations. It is also unclear whether phy-
sicians in general are prepared and equipped with neededBMC Complementary and Alternative Medicine 2002, 2 http://www.biomedcentral.com/1472-6882/2/8
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information to consult their patients on the CAM use. Fu-
ture research will inform us about these areas.
The concern our study raises is the important role that
mass media plays as a source of patient information about
CAM therapies. Studies of direct to consumer advertising
of conventional pharmaceuticals have shown that such
information may be less than accurate and unbiased [16–
19]. The possibility that CAM therapies are being market-
ed unscrupulously to persons desperate to try anything
has to be considered and should be the subject of further
study. This is particularly pressing as there are to our
knowledge, no convincing data that any of these CAM
products are effective for two of the most common prima-
ry reasons these patients gave for using CAM, namely, "to
boost the immune system" and "to cure cancer" [20,21].
However, even if CAM use does not cure cancer or boost
the immune system, CAM use may have other health ben-
efits in addition to the primary stated reason of relieving
symptoms and reducing stress, such as increasing quality
of life through a feeling of control and empowerment.
These are additional areas for fruitful research.
Our study's primary limitation is that we studied patients
with a single type of cancer at a single institution. This re-
striction, however, afforded the opportunity to use face-
to-face interviews to delve more deeply into understand-
ing CAM use than would have been possible in a national
survey. Further research will be required involving pa-
tients with other types of advanced cancer or who get care
in other settings.
In conclusion, we found that the great majority of women
with advanced breast cancer used CAM therapy and most
patients using ingested CAM therapies discussed their use
with their medical doctors. Mass media plays a large role
as a source of patient information. The importance of un-
biased information available to both patients and physi-
cians is emphasized by this study.
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